Total debt has held flat near $2.3B while equity rose to $1.4B, lowering debt-to-equity from 1.93 to 1.27 over the period, though the 5.9% operating margin leaves limited room to service this fixed obligation.
Ardent Health Inc. (ARDT) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Total Current Assets | 2.17B | 2.06B | 1.83B | 1.62B | 1.41B | 860.42M | 736.42M | 471.15M |
| Cash & Short-Term Investments | 766.24M | 709.6M | 556.78M | 437.58M | 456.12M | 59.66M | 71.96M | 92.61M |
| Cash Only | 766.24M | 709.6M | 556.78M | 437.58M | 456.12M | 59.66M | 71.96M | 92.61M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 661.85M | 686.1M | 743.03M | 785.76M | 611.96M | 529.12M | 453.85M | 261.04M |
| Days Sales Outstanding | 38.92 | 39.6 | 45.46 | 53.02 | 43.54 | 46.4 | 55.18 | 45.26 |
| Inventory | 110.1M | 118.59M | 115.09M | 105.48M | 107.15M | 84.81M | 84.16M | 47.09M |
| Days Inventory Outstanding | 8.19 | 278.01 | 40.66 | 273.37 | 40.95 | - | - | - |
| Other Current Assets | 512.54M | 544.53M | 304.09M | 211.99M | 165.05M | 100.57M | 66.82M | 31.08M |
| Total Non-Current Assets | 3.18B | 3.23B | 3.12B | 3.48B | 3.45B | 1.89B | 1.64B | 614.21M |
| Property, Plant & Equipment | 2.11B | 2.14B | 2.04B | 2.01B | 1.99B | 839.89M | 591.57M | 256.53M |
| Fixed Asset Turnover | 3.06x | 2.95x | 2.93x | 2.69x | 2.58x | 4.96x | 5.07x | 8.21x |
| Goodwill | 861.86M | 879.45M | 852.08M | 844.7M | 844.7M | 822.03M | 818.19M | 244.49M |
| Intangible Assets | 87.02M | 89.33M | 76.93M | 76.93M | 76.93M | 77.83M | 78.26M | 71.78M |
| Long-Term Investments | 2K | 0 | 11.46M | 17.8M | 29.4M | 0 | 0 | 0 |
| Other Non-Current Assets | 116.86M | 111.69M | 131.5M | 129.31M | 93.98M | 50.11M | 62.83M | 37.76M |
| Total Assets | 5.35B | 5.29B | 4.96B | 5.1B | 4.86B | 2.75B | 2.37B | 1.09B |
| Asset Turnover | 1.22x | 1.20x | 1.20x | 1.06x | 1.06x | 1.52x | 1.26x | 1.94x |
| Asset Growth % | 22.58% | 6.74% | -2.87% | 5% | 76.96% | 15.66% | 118.78% | - |
| Total Current Liabilities | 1.02B | 1.05B | 945.42M | 994.1M | 808.6M | 624.83M | 507.35M | 328.14M |
| Accounts Payable | 399.04M | 457.94M | 401.25M | 474.54M | 320.8M | 230.36M | 226.48M | 131.94M |
| Days Payables Outstanding | 30.08 | 1.07K | 141.76 | 1.23K | 122.59 | - | - | - |
| Short-Term Debt | 28.76M | 23.44M | 9.23M | 61.03M | 58.42M | 8.96M | 16.88M | 7.67M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 55.26M | 565.16M | 44.66M | 172.82M | 167.84M | 190.75M | 56.7M | 39.98M |
| Current Ratio | 2.13x | 1.97x | 1.94x | 1.63x | 1.74x | 1.38x | 1.45x | 1.44x |
| Quick Ratio | 2.03x | 1.85x | 1.82x | 1.52x | 1.61x | 1.24x | 1.29x | 1.29x |
| Cash Conversion Cycle | 17.03 | -755.89 | -55.64 | -903.42 | -38.1 | - | - | - |
| Total Non-Current Liabilities | 2.55B | 2.56B | 2.49B | 3.03B | 3B | 1.41B | 1.11B | 361.22M |
| Long-Term Debt | 1.07B | 1.08B | 1.07B | 1.15B | 1.15B | 1.25B | 935.81M | 232.7M |
| Capital Lease Obligations | 4.67B | 1.17B | 1.16B | 1.18B | 1.18B | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 371.21M | 381.03M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 317.6M | 317.69M | 261.75M | 319.55M | 290.01M | 157.7M | 171.09M | 128.51M |
| Total Liabilities | 3.57B | 3.61B | 3.43B | 4.02B | 3.81B | 2.03B | 1.61B | 689.36M |
| Total Debt | 2.27B | 2.26B | 2.28B | 2.4B | 2.39B | 1.26B | 952.69M | 240.37M |
| Net Debt | 1.5B | 1.55B | 1.73B | 1.96B | 1.93B | 1.2B | 880.73M | 147.76M |
| Debt / Equity | 1.27x | 1.34x | 1.50x | 2.21x | 2.27x | 1.77x | 1.25x | 0.61x |
| Debt / EBITDA | 4.62x | 4.71x | 4.13x | 6.47x | 6.72x | 4.30x | 4.12x | 1.54x |
| Net Debt / EBITDA | 3.06x | 3.23x | 3.13x | 5.29x | 5.44x | 4.10x | 3.81x | 0.95x |
| Interest Coverage | 6.22x | 6.19x | 6.54x | 3.20x | 4.80x | 0.94x | 1.72x | 2.65x |
| Total Equity | 1.78B | 1.68B | 1.52B | 1.08B | 1.05B | 711.84M | 760.28M | 396.01M |
| Equity Growth % | 36.58% | 10.68% | 40.66% | 3.05% | 47.55% | -6.37% | 91.99% | - |
| Book Value per Share | 12.57 | 11.91 | 11.47 | 7.55 | 7.33 | 5.05 | 5.39 | 2.81 |
| Total Shareholders' Equity | 1.4B | 1.69B | 1.13B | 670.9M | 639.05M | 331.64M | 377.72M | 266.54M |
| Common Stock | 1.41M | 1.43M | 1.43M | 496.88M | 510.97M | 504.69M | 401.86M | 255.03M |
| Retained Earnings | 602.87M | 501.61M | 365.8M | 155.45M | 101.55M | -167.16M | -24.14M | 11.51M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 5.46M | -3.61M | 9.74M | 18.56M | 26.53M | -5.89M | 0 | 0 |
| Minority Interest | 385.5M | -1.25M | 390.98M | 411.42M | 411.26M | 380.19M | 382.55M | 129.47M |
Quick answers to the most common questions about buying ARDT stock.
As of 2025, Ardent Health Inc. (ARDT) had total assets of $5.29B including $2.06B in current assets.
Ardent Health Inc. (ARDT) carries total debt of $2.26B, offset by $709.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ardent Health Inc. (ARDT) has total shareholders' equity (book value) of $1.69B ($11.91 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ardent Health Inc. (ARDT) reported a current ratio of 1.97x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Thin margins and leverage
Metrics are mathematically derived from official filings.
Equity Rebuilding Offsets Stable Leverage
Based on reported figures, ARDT's equity rose from $739.9M in 2024Q2 to $1.4B in 2026Q3 while total debt held near $2.3B, lowering debt-to-equity from 1.93 to 1.27 over the period.
The improvement appears driven primarily by retained earnings growth, which climbed from $225.3M to $602.9M, rather than by any reduction in borrowing. This suggests the deleveraging is earnings-driven and therefore dependent on sustained profitability, which the recent EPS misses call into question. Investors should monitor whether retained earnings continue to build as margins remain thin.
Fixed Debt Burden Against Thin Margins
According to the reported balance sheet, ARDT carries roughly $2.3B of total debt against a 5.15% operating margin, and while the debt level has been flat, its relative weight has declined as equity expanded.
Debt has remained essentially unchanged across ten quarters, indicating management has not pursued aggressive refinancing or paydown, and the leverage improvement reflects the denominator rather than the numerator. With operating margins this narrow, interest and principal obligations consume a meaningful share of operating earnings. This warrants further investigation into the maturity profile and cost of this debt, which the provided data does not disclose.
Cash Buffer Strengthening Gradually
Based on ARDT's reported figures, cash rose from $334.5M to $766.2M over the period while the current ratio held between 1.9 and 2.1, suggesting short-term obligations remain comfortably covered.
The growth in cash reserves provides a larger buffer against working capital reversals, which prior cash flow analysis identified as a principal source of reported cash volatility. A current ratio above 2.0 in most recent quarters indicates adequate near-term liquidity coverage. The cash build is positive, though the data does not reveal how much is restricted or earmarked for facility obligations.
Goodwill and PPE Anchor Asset Base
As reported in financial statements, ARDT's total assets of roughly $5.4B include about $862M of goodwill and $2.1B of net PP&E, together representing a majority of the asset base for this facility-intensive operator.
The asset mix is consistent with a capital-heavy hospital operator, where physical facilities anchor the balance sheet and support the regional density strategy. Goodwill has declined modestly from $877M to $862M over recent quarters, which may reflect minor adjustments rather than impairment, though the data alone does not confirm this. Continued scrutiny of goodwill values is warranted given the acquisition-driven footprint.
Equity Growth Masks Earnings Fragility
The strongest bear case is that ARDT's equity expansion depends on retained earnings built from a 2.1% net margin, leaving the balance sheet vulnerable if reimbursement pressure or labor inflation erodes profitability.
Because the improvement in debt-to-equity rests on earnings retention rather than external capital or debt reduction, a sustained margin decline would reverse the trend and push leverage back toward prior levels. The combination of fixed debt, thin operating margins, and EPS misses suggests limited cushion against shocks such as reduced government supplemental payments. Investors should monitor quarterly retained earnings growth as the key indicator of whether this balance sheet strengthening is durable.